ITMCTR1900002625
Recruiting
Phase 1
A Randomized Controlled Trial for Neural Circuit Based Taichi Yunshou Action Observation Training Combined With Motor Imagery for Stroke Rehabilitation
ational Natural Science Foundation of China0 sitesTBD
Conditionsstroke
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- stroke
- Sponsor
- ational Natural Science Foundation of China
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. The first cerebral infarction which accords with the diagnosis standard of Chinese and Western medicine and belongs to unilateral brain;
- •2\. Aged 20\-75 years, regardless of gender;
- •3\. Right\-handed;
- •4\. The onset was more than 1 month and less than 2 years.
- •5\. Primary school and above education level;
- •6\. No severe aphasia (Aphasia Screening Scale);
- •7\. Simple Mental State Scale screening results showed that there was no cognitive impairment.
- •8\. The degree of motor dysfunction of affected limbs was Brunnstrom grade II\-VI.
- •9\. It has certain motor imagery function. The motor imagery questionnaire has 25 points or more.
- •10\. Can tolerate half an hour to one hour of training or testing;
Exclusion Criteria
- •1\. Neurological diseases, including epilepsy, which seriously affect the completion of the trial program.
- •2\. there are contraindications of MRI, such as pacemaker, metal implant, etc.
- •3\. Excessive pain exists in limb joints.
- •4\. Cranial fractures and/or severe head injuries;
- •5\. History of head and/or brain surgery;
- •6\. Severe visual or auditory impairment, unable to cooperate with training;
- •7\. Three cycles of antidepressants and psychotropic tranquilizers were taken 30 days before the trial.
- •8\. Other drugs to reduce seizure threshold were taken 30 days before the trial.
- •9\. Severe diseases of liver, kidney, heart, lung and blood system were found.
- •10\. Excessive sensitivity or mental illness;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
**NeuroCue*, a randomized controlled study into the use of an electronic cognitive aid in patients with acquired brain injury*cognitive disorders after brain injury/problems with memory and planning after brain damage1004225810009841NL-OMON33708niversiteit Maastricht140
Active, not recruiting
Not Applicable
A Randomized Pilot Study on Central Nervous System (CNS) Prophylaxiswith Liposome-Encapsulated Cytarabine (DepoCyte) in a Population of Adult Patientswith Acute Lymphoblastic Leukemia (ALL) Treated with an Updated and Lineage-TargetedMinimal Residual Disease (MRD)-Oriented Postremission Strategy. - NILG-ALL 10/072. Diagnosis of untreated ALL with B-/T-precursor phenotype or B/T-LL, either de novo or secondary to chemo-radiotherapy for other cancer.MedDRA version: 9.1Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersEUCTR2007-006652-19-ITILG
Completed
Not Applicable
Randomized controlled trial of neurostimulation treatment for apathy in schizophreniaapathylistlessnesspsychosis10039628NL-OMON41353niversitair Medisch Centrum Groningen150
Completed
Not Applicable
Cognitive-behaviour therapy for adolescents with body dysmorphic disorderPersonality disordersMental and Behavioural DisordersPersonality disorder, unspecifiedISRCTN67699666King's College London (UK)30
Completed
Not Applicable
Big White Wall Live Therapy RCTMental HealthMental and Behavioural DisordersISRCTN13496713orth East London NHS Foundation Trust (UK)100